Identifying risk factors for metastasis to the level VII lymph node in papillary thyroid carcinoma patients.
Jian ChenDeguang ZhangLiang FangGaofei HeLi GaoPublished in: BMC surgery (2020)
Based on the results of our study, we considered central-compartment lymph node dissection (CLND) as an integral strategy. On the basis of surgery safety, transcervical level VII lymph node dissection could be considered for PTC patients with high risk factors such as ultrasonography-positive lymph nodes, tumor located in middle and lower thirds of the thyroid lobe and the patients without HT. In future, prognostic significance of level VII lymph node dissection should be evaluated through long-term surveillance.
Keyphrases
- lymph node
- end stage renal disease
- risk factors
- ejection fraction
- neoadjuvant chemotherapy
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- radical prostatectomy
- prostate cancer
- public health
- early stage
- magnetic resonance
- robot assisted
- contrast enhanced
- patient reported
- coronary artery bypass
- atrial fibrillation